Sanders-Brown Faculty
CONTACT INFORMATION
Room 311, Sanders-Brown Center On Aging
800 South Limestone Street
Lexington, KY 40536-0230
E-MAIL:
pnels2@email.uky.edu
PHONE: (859) 257-1412 x254
FAX: (859) 323-2866
For a Powerpoint presentation by Dr. Nelson about exciting new ideas in RNA neurobiology, given for the Alzheimer Research Forum, click the following link.
Peter T. Nelson, M.D.,Ph.D.
Associate Professor
Director, Neuropathology Division (UKMC)
Training Director, Neuropathology Fellowship (UKMC)
Core Director, Neuropathology (UK ADC)
Departmental Affiliation(s):
Pathology, Division of Neuropathology
Research Focus:
Non-coding RNA in neurodegenerative disease
In the lab:
(left to right)
Pete Nelson
James Dimayuga
Bernard R. Wilfred
Wang-Xia Wang
Mary Jennings
Kevin Xie
Willa Huang
Guogen Mao

Work on RNA biology may help point toward strategies to 'un-tangle' the biological questions of Alzheimer's disease, such as why neuritic plaques and neurofibrillary tangles develop in the brains of Alzheimer's patients. (lower left figure shows a low-power photomicrograph depicting miRNA in situ hybridization from human hippocampus; and, at lower right, a medium-power photomicrograph shows human brain stained with a silver impregnation technique to highlight the abnormal and unhealthy-appearing brain microenvironment).
Research Interests:
Dr. Pete Nelson is an experimental neuropathologist focusing on
Alzheimer’s disease. Dr Nelson is the Director of the
Neuropathology Division of the Pathology Department, and he also directs
the brain bank and the Neuropathology Core of the University of Kentucky
Alzheimer’s Disease Center. Dr. Nelson is responsible for the
Alzheimer’s Disease Center brain autopsies. These autopsies are
performed with profound respect for the volunteers who are enabling us
to help combat this dreadful disease. Dr. Nelson’s career is
motivated partly by his own grandmother, Sylvia “Tib” Becker, who died
with Alzheimer's disease.
In addition to duties as a neuropathologist, Dr. Nelson is an
experimental researcher focusing on the molecular neurochemistry of the
human brain — in health and in neurodegenerative disease — particularly
in the context of RNA biology. The study of small regulatory RNAs is a
relatively new and unexplored research field with much potential.
Dr. Nelson's work has focused upon microRNAs (miRNAs). He invented new
techniques to analyze and manipulate these small molecules, and studies
how miRNA biology is altered in neurodegenerative diseases. Dr.
Nelson seeks both to understand how miRNAs contribute to disease
pathogenesis, and to explore how specially-designed RNAs may be applied
for therapeutic strategies.
We’re excited about our new paper in press at Brain—
Recent Publications:
Nelson, PT*, Schmitt, FA, Lin, Y, Abner, EL,
Jicha, GA, Patel, E, Thomason, PC, Neltner, JH, Smith, CD, Santacruz,
KS, Sonnen, JA, Poon, LW, Gearing, M, Green, RC, Woodard, JL, Van Eldik,
LJ, Kryscio, RJ, Hippocampal sclerosis in advanced
age: clinical and pathological features in 106 cases Brain,
2011 In Press
Abner, EL, Kryscio, RJ, Schmitt, FA, Santacruz, KS,
Jicha, GA, Lin, Y, Neltner JH, Smith, CD, Van Eldik, LJ, Nelson, PT*,
“End-stage” neurofibrillary tangle pathology in preclinical Alzheimer’s
disease—fact or fiction?, J Alzheimer's Disease, In Press 2011
Jicha, GA, Abner EL, Schmitt, FA, Kryscio, RJ,
Riley, KP, Cooper, GE, Stiles, JN, Mendiondo, MS, Smith CD, Van Eldik,
LJ, and Nelson, PT*, Preclinical AD Workgroup staging:
pathological correlates and potential challenges, Neurobiology of
Aging, In Press 2011
Jicha, GA and Nelson, PT, Management of
frontotemporal dementia: targeting symptom management in such a
heterogeneous disease requires a wide range of therapeutic options,
Neurodegen Dis Management, In Press 2011
Riley, KP, Jicha, GA, Davis, D, Abner, EL, Cooper,
GE, Stiles, N, Smith, CD, Kryscio, RJ, Nelson, PT, Van Eldik LJ,
and Schmitt, FA, Prediction of preclinical Alzheimer’s disease:
Longitudinal rates of change in cognition, J Alzheimer's Disease,
In Press 2011
Niedowicz DM, Nelson PT,
Murphy MP. Alzheimer’s Disease: Pathological Mechanisms and Recent
Insights Curr Neuropharmacol In Press 2010
Madathil SK, Nelson PT*,
Saatman KE, Wilfred BR, MicroRNAs in CNS injury: potential roles and
therapeutic implications, Bioessays, In Press 2010
Wang WX, Huang Q, Hu Y, Stromberg AJ,
Nelson PT*. Patterns of microRNA expression in normal and
early Alzheimer's disease human temporal cortex: white matter versus
gray matter. Acta Neuropathol. 2010 Oct 10.
Wang WX, Kyprianou N, Wang X, Nelson PT*.
Dysregulation of the mitogen granulin in human cancer through the
miR-15/107 microRNA gene group. Cancer Res. 2010 Sep 30.
Finnerty JR, Wang WX, Hébert SS,
Wilfred BR, Mao G, Nelson PT*. The miR-15/107 group of microRNA
genes: evolutionary biology, cellular functions, and roles in human
diseases. J Mol Biol. 2010 Sep 24;402(3):491-509.
Nelson PT*,
Schmitt FA, Jicha GA, Kryscio RJ, Abner EL, Smith
CD, Van Eldik LJ, Markesbery WR. Association between male gender
and cortical Lewy body pathology in large autopsy series. J
Neurol. 2010
Wang WX, Wilfred BR, Madathil SK,
Tang G, Hu Y, Dimayuga J, Stromberg AJ, Huang Q, Saatman KE, Nelson
PT*. miR-107 regulates granulin/progranulin with implications
for traumatic brain injury and neurodegenerative disease. Am J
Pathol. 2010 Jul;177(1):334-45.
Wang WX, Wilfred BR, Xie K,
Jennings MH, Hu Y, Stromberg AJ, Nelson PT*. Individual
microRNAs (miRNAs) display distinct mRNA targeting "rules"
RNA Biol. 2010 May 5;7(3).
Nelson PT*,
Kukull WA, Frosch MP. Thinking outside the
box: Alzheimer-type neuropathology that does not map directly onto
current consensus recommendations. JNEN. 2010 May;69(5):449-54
Nelson PT*,
Wang WX. MiR-107 is Reduced in Alzheimer's
Disease Brain Neocortex: Validation Study. J Alzheimers Dis.
2010
Nelson PT*,
Kiriakidou M, Mourelatos Z, Tan GS, Jennings MH,
Xie K, Wang WX. High-throughput experimental studies to identify
miRNA targets directly, with special focus on the mammalian brain.
Brain Res. 2010 Jun 18;1338:122-30.
Balamuthia mandrillaris
meningoencephalitis: survival of a pediatric patient. Cary LC,
Maul E, Potter C, Wong P, Nelson PT, Given C 2nd, Robertson W Jr.
Pediatrics. 2010 Mar;125(3):e699-703.
Nelson PT*,
Dimayuga J, Wilfred, BR, MicroRNA in situ
hybridization in the human entorhinal and transentorhinal cortex.
Front Hum Neurosci, 2010
Wang W-X, Wilfred BR, Hu Y, Stromberg AJ,
Nelson PT*, Argonaute co-immunoprecipitation with RIP-CHIP show
that miRNA transfection alter global patterns of mRNA recruitment to
microribonucleoprotein complexes. RNA, 2010.
Nelson PT*,
Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, Xu LO, Smith CD,
Markesbery WR. Low sensitivity in clinical diagnoses of dementia
with Lewy bodies. J Neurol. 2009 Oct 1.
Nelson, PT*,
Kryscio, RJ, Jicha, GA, Abner, EL, Schmitt, FA, Xu, L, Cooper, G, Smith,
CD, Markesbery, WR, Relative preservation of MMSE scores in
autopsy-proven dementia with Lewy bodies, Neurology (2009)
Nelson, PT*,
Kryscio, RJ, Jicha, GA, Abner, EL, Schmitt, FA, Xu, L, Cooper, G, Smith,
CD, Markesbery, WR, Brains with medial temporal lobe neurofibrillary
tangles but no neuritic amyloid plaques are a diagnostic dilemma but may
have pathogenetic aspects distinct from Alzheimer disease. J
Neuropathol Exp Neurol. 2009 Jul;68(7):774-84
Berger JR, Fee DB, Nelson P,
Nuovo G. Coxsackie B meningoencephalitis in a patient with acquired
immunodeficiency syndrome and a multiple sclerosis-like illness.
J Neurovirol. 2009 May 14:1-6.
Berger JR, Dillon DA, Young BA,
Goldstein SJ, Nelson P Cystinosis of the brain and spinal
cord with associated vasculopathy. J Neurol Sci. 2009 Sep
15;284(1-2):182-5. Epub 2009 Apr 22.
Nelson PT*,
Wilfred BR.
In situ hybridization is a necessary
experimental complement to microRNA (miRNA) expression profiling in the
human brain. Neurosci Lett. 2009 Apr 23.
Nelson PT*,
Abner, EA, Scheff, SW, Schmitt, FA, Kryscio, RJ, Jicha, GA, Smith, CD,
Patel, E, Markesbery, WR, Alzheimer pathology in the precuneus is not
increased relative to other areas of neocortex across a range of
cognitive impairment. Neurosci Letters, 2009.
Nelson PT*,
Braak H, and Markesbery WR, Neuropathology and
Cognitive Impairment in Alzheimer’s Disease: A Complex but Coherent
Relationship. J Neuropathol Exp Neurol. 2009
Jan;68(1):1-14.
Nelson PT*,
Abner, EA, Schmitt, FA, Kryscio, RJ, Jicha, GA, Smith, CD, Davis, DG,
Poduska, JW, Patel, E, Mendiondo, MS, Markesbery, WR, Modeling the
association between 43 different clinical and pathological variables and
the severity of cognitive impairment in a large autopsy cohort of
elderly persons. Brain Pathol, (2008).
Jicha, GA, Schmitt, FA, Abner, EL,
Nelson, PT, Cooper, GE, Smith, CD, and Markesbery, WR, Prodromal
clinical manifestations of neuropathologically confirmed Lewy body
disease. Neurobiol Aging, 2008
Nelson PT*,
Smith, CD, Abner, EA, Schmitt, FA, Scheff, SW, Davis, GD, Keller, JN,
Jicha, GA, Davis, D, Wang, W-X, Hartman, A, Katz, DG, and Markesbery WR,
Human cerebral neuropathology of Type 2 diabetes mellitus.
BBA-Mol Basis of Disease, 2008
Nelson PT*,
Kryscio, RJ, Abner, EA, Schmitt, FA, Jicha, GA, Mendiondo, MS, Cooper,
G, Smith, CB, and Markesbery, WR, Acetylcholinesterase inhibitor
treatment is associated with relatively slow cognitive decline in
patients with Alzheimer’s disease and AD+DLB. J Alzheim Dis,
2008
Nelson PT*,
Wang WX, Wilfred BR, Tang G. Technical variables in
high-throughput miRNA expression profiling: Much work remains to be
done. Biochim Biophys Acta. 2008 Apr 7.
Cuellar TL, Davis TH, Nelson PT,
Loeb GB, Harfe BD, Ullian E, McManus MT. Dicer loss in striatal
neurons produces behavioral and neuroanatomical phenotypes in the
absence of neurodegeneration. Proc Natl Acad Sci U S A.
2008 Apr 8;105(14):5614-9.
Wang WX, Wilfred BR, Baldwin DA, Isett
RB, Ren N, Stromberg A, Nelson PT*. Focus on RNA isolation:
Obtaining RNA for microRNA (miRNA) expression profiling analyses of
neural tissue. Biochim Biophys Acta. 2008 Feb 13.
Wang, W-X, Nelson PT, and
Tang, G, RNA interference and miRNA pathways: mechanisms and protein
machinery. Wiley Encyclopedia of Chemical Biology.
2008
Wang W-X, Rajeev, BW, Stromberg
AJ, Ren N, Tang G, Huang Q, Rigoutsos I, and Nelson PT*.
The expression of microRNA miR-107 decreases early in Alzheimer’s
disease and may accelerate disease progression through regulation of
BACE1. J Neuroscience 2008 28(5): 1213-23.
Nelson PT*,
Wang, W-X, and Rajeev, BW. MicroRNAs in neurodegeneration.
Brain Pathology 2008 18(1): 130-8.
